Tower Research Capital (TRC)’s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share JEMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio JEMD Stock Details JEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-405	Closed	-$3K	–	6941
2022 Q1	$3K	Buy	405 +324	+400%	+$2.35K	﹤0.01%	5485
2021 Q4	$1K	Buy	+81	New	+$629	﹤0.01%	6032
2020 Q3	–	Sell	-11	Closed	–	–	5231
2020 Q2	$0	Buy	+11	New	+$72	﹤0.01%	5100
2019 Q2	–	Sell	-31	Closed	–	–	4527
2019 Q1	$0	Buy	+31	New	+$261	﹤0.01%	4491

Other funds holding JEMD

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SFS

Shaker Financial Services Arlington, Virginia $319M AUM 3.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Tower Research Capital (TRC)'s JEMD Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share (JEMD) in Q2 2022, closing a stake of 405 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in JEMD in Q1 2019 and held it in 4 quarters. The position peaked at $3K in Q1 2022. 25 funds tracked by Wall St. Rank hold JEMD as of Q2 2022.

Tower Research Capital (TRC) reported no remaining Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position as of Q2 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 405 Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share shares in Q2 2022, an estimated $3K.
Tower Research Capital (TRC) first reported a position in Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q1 2019 and held it in 4 quarters.
Tower Research Capital (TRC)'s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position peaked at $3K in Q1 2022.
25 funds tracked by Wall St. Rank held Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.